General form of registration statement for all companies including face-amount certificate companies

CONSOLIDATED STATEMENTS OF OPERATIONS

 v2.3.0.11
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Dec. 31, 2010
Dec. 31, 2009
Revenue (Sales) $ 272,266 $ 1,800 $ 49,784 $ 27,612
Other Income - Therapeutic Grant Credit 143,540      
Total revenue 415,806 1,800    
Operating expenses:        
Costs of goods sold 93,650 1,000 27,964 20,112
Research and development 797,055 215,443 363,781 540,300
General and administrative 930,393 244,665 590,826 280,709
Sales and marketing costs 230,704      
Amortization and depreciation 87,802 80,932 164,456 144,792
Costs and Expenses, Total 2,139,604 542,040 1,147,027 985,913
Operating loss (1,723,798) (540,240) (1,097,243) (958,301)
Interest expense and debt expense:        
Shareholders (Members) (18,776) (121,400) (265,221) (256,803)
Other (12,413) (28,477) (61,183) (11,700)
Net loss (1,754,987) (690,117) (1,423,647) (1,226,804)
Net loss attributable to non-controlling interest 1,707 4 15 119
Net loss attributed to common shareholders (Members) $ (1,753,280) $ (690,113) $ (1,423,632) $ (1,226,685)
Loss per common share (unit) - basic and diluted $ (0.07) $ (0.08) $ (0.11) $ (0.23)
Common shares (Units) used in basic earnings per share calculation 25,556,710 9,153,410 12,437,983 5,304,423